The PEDAP trial. The Pediatric Artificial Pancreas (PEDAP) clinical trial was conducted to compare the efficacy and safety of closed-loop insulin delivery with standard care in children with type 1… Continue reading Closed-loop insulin pump for children ages 2-6
Device
Artificial pancreas in the hospital
The automated insulin pump has already shown great results in type 1 diabetes in an ambulatory setting. This study shows that it is as useful in type 2 diabetes patients treated in the hospital. Patients utilizing the “artificial pancreas” had better glycemic control, without an increased risk of hypoglycemia. I anticipate that closed-loop, automated insulin devices will become the “standard of care” for hospitalized patients with type 1 and type 2 diabetes in the future.
GT
The semi-automated insulin pump performs well
The study reveals that the hybrid closed loop device, MiniMed 670g, helps in reducing A1c by 0.75% compared to standard insulin pumps. For those transitioning to it, carbohydrate to insulin ratio needs to be adjusted immediately. This semi-automated system, differently called semi-artificial pancreas, is a significant advancement in the field of type 1 diabetes. The device was approved by FDA in September 2016.
GT
How to insert FreeStyle Libre – the glucometer without fingersticks
FreeStyle Libre is the first glucometer without the use of fingersticks for measurements or calibration. It received the FDA approval in September 2017. Below is a nice video on how to apply the sensor and use the scanner.
GT